BROSHY ERAN
Insider CIK 1256230 · TBPH Director · CERT Director · MGLN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CERT Certara, Inc. | A Award deriv | 2026-05-14 | 2026-05-15 | 33,222 | — | $0 | 33,222 | SEC↗ |
| CERT Certara, Inc. | M Exercise deriv | 2026-05-14 | 2026-05-15 | 15,757 | — | $0 | 0 | SEC↗ |
| CERT Certara, Inc. | M Exercise | 2026-05-14 | 2026-05-15 | 15,757 | — | $0 | 50,708 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | M Exercise deriv | 2025-11-26 | 2025-12-01 | 14,000 | $10.15 | $142.1K | 81,749 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2025-11-26 | 2025-12-01 | 14,000 | $20.00 | $280.0K | 60,204 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2025-11-26 | 2025-12-01 | 15,501 | $20.00 | $310.0K | 44,703 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | M Exercise deriv | 2025-11-11 | 2025-11-13 | 14,000 | $10.15 | $142.1K | 107,878 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | M Exercise deriv | 2025-11-11 | 2025-11-14 | 14,000 | $10.15 | $142.1K | 107,878 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2025-11-11 | 2025-11-13 | 29,500 | $18.50 | $545.8K | 61,704 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2025-11-11 | 2025-11-13 | 14,000 | $18.50 | $259.0K | 46,204 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2025-11-11 | 2025-11-13 | 15,500 | $17.00 | $263.5K | 46,204 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2025-11-11 | 2025-11-14 | 15,500 | $17.00 | $263.5K | 60,204 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2025-11-11 | 2025-11-14 | 15,500 | $18.50 | $286.8K | 75,704 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | S Sale | 2025-11-11 | 2025-11-14 | 14,000 | $18.50 | $259.0K | 60,204 | SEC↗ |
| CERT Certara, Inc. | M Exercise deriv | 2025-05-21 | 2025-05-22 | 11,928 | — | $0 | 0 | SEC↗ |
| CERT Certara, Inc. | A Award deriv | 2025-05-21 | 2025-05-22 | 15,757 | — | $0 | 15,757 | SEC↗ |
| CERT Certara, Inc. | M Exercise | 2025-05-21 | 2025-05-22 | 11,928 | — | $0 | 34,951 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2025-05-19 | 2025-05-21 | 24,258 | — | $0 | 24,258 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2025-05-19 | 2025-05-21 | 10,649 | — | $0 | 91,204 | SEC↗ |
| CERT Certara, Inc. | A Award deriv | 2024-05-21 | 2024-05-23 | 11,928 | — | $0 | 11,928 | SEC↗ |
| CERT Certara, Inc. | M Exercise deriv | 2024-05-21 | 2024-05-23 | 8,663 | — | $0 | 0 | SEC↗ |
| CERT Certara, Inc. | M Exercise | 2024-05-21 | 2024-05-23 | 8,663 | — | $0 | 23,023 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2024-05-08 | 2024-05-10 | 23,576 | — | $0 | 23,576 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2024-05-08 | 2024-05-10 | 10,537 | — | $0 | 80,555 | SEC↗ |
| CERT Certara, Inc. | P Buy | 2023-08-22 | 2023-08-23 | 4,807 | $15.80 | $76.0K | 14,360 | SEC↗ |
| CERT Certara, Inc. | P Buy | 2023-08-21 | 2023-08-23 | 193 | $16.10 | $3.1K | 9,553 | SEC↗ |
| CERT Certara, Inc. | A Award deriv | 2023-05-23 | 2023-05-25 | 8,663 | — | $0 | 8,663 | SEC↗ |
| CERT Certara, Inc. | M Exercise deriv | 2023-05-23 | 2023-05-25 | 9,360 | — | $0 | 0 | SEC↗ |
| CERT Certara, Inc. | M Exercise | 2023-05-23 | 2023-05-25 | 9,360 | — | $0 | 9,360 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2023-05-02 | 2023-05-04 | 22,044 | — | $0 | 22,044 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2023-05-02 | 2023-05-04 | 9,132 | — | $0 | 70,018 | SEC↗ |
| CERT Certara, Inc. | A Award deriv | 2022-07-13 | 2022-07-15 | 9,360 | — | $0 | 9,360 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2022-04-26 | 2022-04-28 | 28,000 | — | $0 | 28,000 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2022-04-26 | 2022-04-28 | 9,852 | — | $0 | 60,886 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2021-04-27 | 2021-04-29 | 6,000 | — | $0 | 6,000 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2021-04-27 | 2021-04-29 | 9,828 | — | $0 | 51,034 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2020-04-28 | 2020-04-30 | 6,000 | — | $0 | 6,000 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2020-04-28 | 2020-04-30 | 6,635 | — | $0 | 41,206 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2019-04-30 | 2019-05-02 | 6,000 | — | $0 | 6,000 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2019-04-30 | 2019-05-02 | 8,385 | — | $0 | 34,571 | SEC↗ |
| MGLN MAGELLAN HEALTH INC | A Award | 2018-05-24 | 2018-05-25 | 1,685 | — | $0 | 9,645 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2018-05-01 | 2018-05-03 | 6,000 | — | $0 | 6,000 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2018-05-01 | 2018-05-03 | 8,186 | — | $0 | 26,186 | SEC↗ |
| MGLN MAGELLAN HEALTH INC | A Award | 2017-05-24 | 2017-05-26 | 2,137 | — | $0 | 10,097 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2017-05-17 | 2017-05-18 | 6,000 | — | $0 | 18,000 | SEC↗ |
| MGLN MAGELLAN HEALTH INC | S Sale | 2017-02-23 | 2017-02-27 | 4,867 | $80.00 | $389.4K | 7,960 | SEC↗ |
| MGLN MAGELLAN HEALTH INC | S Sale | 2016-12-08 | 2016-12-12 | 2,433 | $75.00 | $182.5K | 12,827 | SEC↗ |
| MGLN MAGELLAN HEALTH INC | A Award | 2016-05-18 | 2016-05-20 | 2,295 | — | $0 | 15,260 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2016-05-03 | 2016-05-05 | 6,000 | — | $0 | 12,000 | SEC↗ |
| MGLN MAGELLAN HEALTH INC | A Award | 2015-05-20 | 2015-05-22 | 2,235 | — | $0 | 12,965 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award | 2015-04-22 | 2015-04-24 | 6,000 | — | $0 | 6,000 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2014-06-03 | 2014-06-05 | 12,000 | — | $0 | 12,000 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2014-06-03 | 2014-06-05 | 12,000 | — | $0 | 12,000 | SEC↗ |
| MGLN MAGELLAN HEALTH SERVICES I | A Award | 2014-05-21 | 2014-05-23 | 2,104 | — | $0 | 10,730 | SEC↗ |
| MGLN MAGELLAN HEALTH SERVICES I | A Award | 2013-05-22 | 2013-05-24 | 2,367 | — | $0 | 8,626 | SEC↗ |
| MGLN MAGELLAN HEALTH SERVICES I | A Award | 2012-05-16 | 2012-05-17 | 2,959 | — | $0 | 13,559 | SEC↗ |